Euglena Co., Ltd.

2931

JP3944370000

Food Processing

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-31 am EDT			5-day change	1st Jan Change
540 ^JPY	-1.10%		+1.50%	-22.53%

May. 16	Euglena Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ended December 31, 2024	CI
Mar. 13	Seiichiro Kametani agreed to acquire Hako inc. from Euglena Co., Ltd. for ¥600 million.	CI

Euglena Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ended December 31, 2024

May 16, 2024 at 02:00 am EDT

Euglena Co., Ltd. provided consolidated earnings guidance for the year ended December 31, 2024. for the year, the company expects Net sales of JPY 52,500 million.

Latest news about Euglena Co., Ltd.

Euglena Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ended December 31, 2024	May. 16	CI
Seiichiro Kametani agreed to acquire Hako inc. from Euglena Co., Ltd. for ¥600 million.	Mar. 12	CI
Japanese Shares Track Other Asia Stocks Lower Despite China's Rate Cut	Feb. 20	MT
Euglena Slightly Narrows 2023 Attributable Loss as Net Sales Grow	Feb. 19	MT
Zenhoren Co.,Ltd. agreed to acquire 18.93% stake in Okinawa Basketball Co., Ltd from Euglena Co., Ltd. for ¥360 million.	Jan. 23	CI
KAICO, Ltd. announced that it has received ¥810 million in funding from a group of investors	Jan. 18	CI
Euglena Co., Ltd. agreed to acquire Saticine Medical Co., Ltd.	Jan. 09	CI
Euglena Co., Ltd. agreed to acquire Japan Beautech Co., Ltd. from Kirei Sozo Holdings, K.K.	Jan. 09	CI
Euglena Co., Ltd. entered into stock transfer agreement to acquire Nayuta Co., Ltd. from Kirei Sozo Holdings, K.K. and Hiroji Yamazaki for ¥0.0 million.	Jan. 09	CI
Euglena Widens Attributable Loss in Nine Month	Nov. 16	MT
Japanese Shares Extend Gains for Sixth Straight Trading Session; Euglena Rises 3%	23-09-04	MT
Euglena Opens Call for Chief Future Officers Under 18 Years Old	23-09-04	MT
Euglena Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Euglena Sees Attributable Loss Fall in FY22	23-02-17	MT
Euglena Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending Dec. 31, 2023	23-02-16	CI
Euglena Co., Ltd. announced that it has received ¥7.7999475 billion in funding from Marui Group Co., Ltd., Rohto Pharmaceutical Co.,Ltd., Mazda Motor Corporation, Dai-ichi Life Holdings, Inc.	23-02-05	CI
Euglena Co., Ltd. announced that it expects to receive ¥7.7999475 billion in funding from Marui Group Co., Ltd., Rohto Pharmaceutical Co.,Ltd., Mazda Motor Corporation, Dai-ichi Life Holdings, Inc.	23-01-18	CI
Japanese shares end lower on Fed rate hike worries	22-12-15	RE
Japan's Nikkei inch lower on worries over Fed rate hike impact	22-12-14	RE
Italy's Eni eyes biorefinery in Malaysia with Petronas, Euglena	22-12-14	RE
Eni, Euglena, Petronas To Jointly Explore Biorefinery Development In Malaysia	22-12-14	MT
Euglena's Attributable Loss Widens in January-September Period	22-11-18	MT
Euglena Co., Ltd. Provides Consolidated Financial Guidance for the Year Ending December 31, 2022	22-11-17	CI
Euglena’s H1 Loss Widens; Net Sales Soar 179%	22-08-17	MT
Euglena Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2022	22-08-16	CI

euglena Co., Ltd. is a Japan-based company mainly engaged in the healthcare, energy and environmental business utilizing the research and development results on euglena. The Company masters the core technology of euglena, which provides the edibility of microalga euglena (Japanese name: Midorimushi) and the technology of outdoor large-scale cultivation. The Company operates in two business segments. The Healthcare segment is involved in the original equipment manufacturer (OEM) provision of food and cosmetics using euglena, as well as the planning and sale of products. The Energy and Environment segment is involved in the technology development and commissioned research of euglena and other microalgae, as well as the research and development of biofuels for the future commercialization.

Sector

Food Processing

Calendar

2024-08-07 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

540 JPY

Average target price

1,000 JPY

Spread / Average Target

+85.19%

Consensus

Quarterly earnings - Rate of surprise

Company calendar

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
EUGLENA CO., LTD.	-22.53%	468M
ZHEJIANG NHU COMPANY LTD.	+11.85%	8.05B
BELLRING BRANDS, INC.	+5.29%	7.59B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+2.63%	6.07B
THE SIMPLY GOOD FOODS COMPANY	-2.80%	3.85B
BYHEALTH CO., LTD	-11.22%	3.55B
XIAMEN KINGDOMWAY GROUP COMPANY	-7.04%	1.28B
HERBALIFE LTD.	-32.50%	1.03B
SIRIO PHARMA CO., LTD.	+12.52%	971M
USANA HEALTH SCIENCES, INC.	-11.19%	907M

Special Foods & Wellbeing Products

Euglena Co., Ltd.

Equities

2931

JP3944370000

Food Processing

Euglena Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ended December 31, 2024

Latest news about Euglena Co., Ltd.

Chart Euglena Co., Ltd.

Company Profile

Income Statement Evolution

Analysts' Consensus

Quarterly earnings - Rate of surprise

Sector Special Foods & Wellbeing Products